Related Experiment Video
Updated: Jul 6, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Morphine in the management of dyspnoea in ALS. A pilot study
1Department of Science and Research, Centre for Palliative Medicine, University of Bonn, Germany. katri-elina.clemens@malteser.de
Background And Purpose:
The study aimed to verify the efficacy and safety of morphine in the management of dyspnoea in patients with terminal amyotrophic lateral sclerosis (ALS). A further aim was to assess the effect of morphine on ventilation and the potential diminishing effect of nasal O(2)-insufflation preceding morphine administration on the intensity of dyspnoea.
Methods:
Six dyspnoeic ALS patients were included in a prospective, non-randomized study. The intensity of dyspnoea was measured with a Numeric Rating Scale (NRS 0-10). Transcutaneous carbon dioxide partial pressure (tcpaCO(2)), oxygen saturation (SaO(2)) and pulse frequency were continuously monitored during the nasal insufflation of O(2) preceding the first morphine dose and also afterwards.
Results:
A significant decrease was seen in both respiratory rate (from 42.0 +/- 6.0/min to 29.0 +/- 4.0) (P = 0.027) and the intensity of dyspnoea (from 7.5 +/- 1.9 to 1.8 +/- 0.8) (P = 0.027) 120 min after the morphine administration. Neither a significant tcpaCO(2) increase nor a SaO(2) decrease were seen. O(2)-insufflation did not significantly decrease the intensity of dyspnoea. The anxiety of choking correlated highly significantly with the intensity of dyspnoea (r = 0.861, P = 0.028) in all patients. There were no cases of respiratory depression.
Discussion:
Therapeutic doses of morphine were effective and safe in the management of dyspnoea in ALS patients.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
COPD: Management Using Bronchodilators and Corticosteroids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation